Letter

NICE on bacterial meningitis

Vancomycin may not be necessary

BMJ 2010; 341 doi: 10.1136/bmj.c4704 (Published 27 August 2010)
Cite this as: BMJ 2010;341:c4704

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Katherine L Henderson, scientist (epidemiology)1,
  2. Berit Muller-Pebody, scientist (epidemiology)1,
  3. Shamez Ladhani, paediatric infectious diseases consultant12,
  4. Mike Sharland, paediatric infectious diseases consultant2,
  5. Alan P Johnson, consultant clinical scientist1
  1. 1Centre for Infections, Health Protection Agency, London NW9 5EQ
  2. 2Paediatric Infectious Disease Unit, St George’s Hospital, London SW17 0QT
  1. Katherine.Henderson{at}hpa.org.uk

    The guidelines from the National Institute for Health and Clinical Excellence (NICE) on the empirical treatment of bacterial meningitis in children recommend intravenous ceftriaxone for children aged ≥3 months and cefotaxime plus ampicillin or amoxicillin for infants aged ≥3 months.1 2 The British National Formulary for Children (BNF-C) recommends similar empirical treatment with cefotaxime or cefotaxime and ampicillin, respectively.3 Whereas the BNF-C …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular